RecruitingNot ApplicableNCT05162651

Effect of Extended Cannabis Abstinence on PTSD Symptoms


Sponsor

Centre for Addiction and Mental Health

Enrollment

24 participants

Start Date

Feb 2, 2022

Study Type

INTERVENTIONAL

Conditions

Summary

This will be a 12-week randomized trial. Outpatients and patients from the Mood and Anxiety program at the Centre for Addiction and Mental Health (CAMH) with a current diagnosis of post-traumatic stressed disorder (PTSD) and cannabis-use disorder (CUD) will be randomized to receive individual motivational interviewing therapy and contingency management (n = 12) or individual motivational interviewing therapy alone (control group, n = 12) after enrolment.


Eligibility

Min Age: 18 YearsMax Age: 55 Years

Plain Language Summary

Simplified for easier understanding

This study is examining how stopping cannabis use for an extended period affects symptoms of PTSD (post-traumatic stress disorder) in people who use cannabis heavily and are also living with PTSD. **You may be eligible if...** - You are 18–55 years old - You have a moderate or severe cannabis use disorder - You have been diagnosed with current PTSD (symptoms in the last 30 days) - You have been taking antidepressant medication for at least 1 month - You can communicate in English and provide written consent **You may NOT be eligible if...** - You have a severe or unstable medical condition - You have schizophrenia, schizoaffective disorder, bipolar disorder, or active psychosis - You are at risk of suicide - You have chronic pain that significantly interferes with your daily life Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

BEHAVIORALContingency-management

In addition to structured assessments at baseline, four, eight and twelve months, subjects randomized to the contingency-management group will receive a contingent bonus if the participants show successful abstinence at the end of weeks 4, 8 and 12.

OTHEREnhanced usual care

Subjects will receive structured, quantitative assessments at baseline, four, eight and twelve weeks.


Locations(1)

Centre for Addiction and Mental Health

Toronto, Ontario, Canada

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT05162651


Related Trials